Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HAE stock price vs CNA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CNA's multiple
Needs CNA P/E.
Implied fair value · at HAE's multiple
Needs HAE P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · CNA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Capital structure 82% equity / 18% debt · EV / Revenue 1.04x · EV / EBITDA 8.31x
CNA carries the larger enterprise value at $15.66B against $5.68B; CNA trades on the lower EV / Revenue multiple (1.04x vs 4.26x); CNA on the lower EV / EBITDA (8.31x vs 21.58x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Haemonetics Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CNA FINANCIAL CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.56x
0.26x
Net debt / EBITDA
Leverage against operating earnings
3.80x
1.35x
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
$425.00M
Total debt
Interest-bearing obligations outstanding
$1.24B
$2.97B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
ALLSTATE CORP
HAE vs ALL
BERKLEY W R CORP
HAE vs WRB
CINCINNATI FINANCIAL CORP
HAE vs CINF
HARTFORD FINANCIAL SERVICES GROUP, INC.
HAE vs HIG
TRAVELERS COMPANIES, INC.
HAE vs TRV
Chubb Ltd
HAE vs CB
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
